Try our Advanced Search for more refined results

Expert Analysis - Opinion

CMS Drug Price Proposal Would Harm Patients, Providers

By Justin Linder (November 1, 2018, 1:04 PM EDT) -- In a speech delivered at the U.S. Department of Health and Human Services on Oct. 25, President Donald Trump unveiled a proposal he touted as a "revolutionary" step to counter "global freeloading" by foreign nations.[1] The International Pricing Index Model, or IPI Model, referenced by the president and detailed in an advanced notice of proposed rule-making, or ANPR, published Oct. 30 by the Centers for Medicare & Medicaid Services[2], however, bears little resemblance to the president's soaring rhetoric and promptly came under intense fire from a diverse cross-section of industry stakeholders....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!